Latest & greatest articles for pressure ulcer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pressure ulcer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pressure ulcer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pressure ulcer

181. A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers

A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers Margolis D J, Lewis V L Authors' objectives To review the efficacy (...) of topical treatments on the healing of stage II to IV pressure sores. Searching MEDLARS was searched from 1966 to 1993, and the reference lists of key articles were examined. Study selection Study designs of evaluations included in the review Studies on humans with chronic stage II to IV pressure sores. Properly controlled trials (with or without randomisation). Specific interventions included in the review Miscellaneous topical agents including sugar, vitamins, elements, minerals, hormones, cytokine

DARE.1995

182. A randomized trial of low-air-loss beds for treatment of pressure ulcers.

A randomized trial of low-air-loss beds for treatment of pressure ulcers. 8338511 1993 02 11 1993 02 11 2016 10 17 0098-7484 269 4 1993 Jan 27 JAMA JAMA A randomized trial of low-air-loss beds for treatment of pressure ulcers. 494-7 To assess the effectiveness of low-air-loss beds for the treatment of pressure ulcers in nursing homes. Prospective, randomized, clinical trial. Three teaching nursing homes in Los Angeles, Calif. Eighty-four nursing home residents with trunk or trochanter pressure ulcers (...) of time compared with those using foam mattresses (combined cure probability ratio, 2.66; 95% confidence interval, 1.34 to 5.17; P < .004). Low-air-loss beds provide substantial improvement compared with foam mattresses despite other factors in pressure ulcer healing. Ferrell B A BA Department of Medicine, UCLA School of Medicine. Osterweil D D Christenson P P eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't

JAMA1993

183. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers.

Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. 8433469 1993 03 15 1993 03 15 2016 10 17 0098-7484 269 9 1993 Mar 03 JAMA JAMA Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. 1139-43 To determine, in critically ill patients at risk, both the clinical utility and cost-effectiveness of using an air suspension bed in the prevention of pressure ulcers. Randomized, parallel group, controlled (...) clinical trial with accompanying cost-effectiveness analysis. 30-bed multidisciplinary intensive care unit. 100 consecutive patients at risk for the development of pressure ulcers randomly assigned to receive treatment on either an air suspension bed or a standard intensive care unit bed. Patients considered at risk were those at least 17 years of age with an Acute Physiology and Chronic Health Evaluation II (APACHE II) score greater than 15 who had an expected intensive care unit stay of at least 3

JAMA1993

184. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.

Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. 1345953 1992 02 13 1992 02 13 2016 11 23 0140-6736 339 8784 1992 Jan 04 Lancet (London, England) Lancet Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. 23-5 A randomised, phase I/II, double-blind, placebo-controlled study was designed to assess the effect of topically applied recombinant human BB homodimeric platelet-derived growth factor (rPDGF-BB) on healing of chronic pressure ulcers (...) Combined Modality Therapy Double-Blind Method Drug Administration Schedule Follow-Up Studies Humans Middle Aged Platelet-Derived Growth Factor therapeutic use Pressure Ulcer drug therapy Proto-Oncogene Proteins c-sis Recombinant Proteins therapeutic use Wound Healing drug effects 1992 1 4 1992 1 4 0 1 1992 1 4 0 0 ppublish 1345953 0140-6736(92)90143-Q

Lancet1992